Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.66 USD | -0.29% | +2.64% | -16.43% |
May. 14 | Transcript : Gilead Sciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM | |
May. 09 | Declaration of Voting Results by Gilead Sciences | CI |
Financials (USD)
Sales 2024 * | 27.6B | Sales 2025 * | 27.98B | Capitalization | 84.54B |
---|---|---|---|---|---|
Net income 2024 * | 403M | Net income 2025 * | 6.35B | EV / Sales 2024 * | 3.72 x |
Net Debt 2024 * | 18.15B | Net Debt 2025 * | 12.68B | EV / Sales 2025 * | 3.47 x |
P/E ratio 2024 * |
195
x | P/E ratio 2025 * |
13.1
x | Employees | 18,000 |
Yield 2024 * |
4.56% | Yield 2025 * |
4.78% | Free-Float | 99.89% |
Latest transcript on Gilead Sciences, Inc.
1 day | +1.29% | ||
1 week | +5.10% | ||
Current month | +4.10% | ||
1 month | +0.84% | ||
3 months | -5.18% | ||
6 months | -8.92% | ||
Current year | -16.21% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 59 | 19-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 54 | 15-12-31 |
Flavius Martin
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Welters
BRD | Director/Board Member | 69 | 20-10-16 |
Director/Board Member | 71 | 17-12-31 | |
Ted Love
BRD | Director/Board Member | 65 | Jan. 31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.99% | 254 M€ | +10.74% | - | |
8.10% | 0 M€ | 0.00% | - | |
8.06% | 0 M€ | 0.00% | - | |
5.23% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 67.71 | -0.22% | 1 484 256 |
24-05-16 | 67.86 | +1.27% | 4,831,970 |
24-05-15 | 67.01 | -0.95% | 7,532,064 |
24-05-14 | 67.65 | +0.16% | 4,356,239 |
24-05-13 | 67.54 | +2.40% | 6,736,457 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.21% | 84.54B | |
+32.36% | 694B | |
+30.12% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.40% | 239B | |
+10.14% | 209B | |
-3.19% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- GILD Stock